Nu Skin Enterprises Inc (NUS)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 48,268 59,664 65,745 74,766 110,847 103,707 189,375 223,224 233,992 302,370 311,214 283,912 257,564 223,546 219,210 235,338 267,426 231,178 241,961 250,523
Long-term debt US$ in thousands 478,040 362,896 367,753 372,609 377,466 382,323 387,179 258,995 268,781 278,563 288,343 298,120 305,393 312,664 319,932 327,197 334,461 341,724 348,986 356,247
Total stockholders’ equity US$ in thousands 821,968 822,187 895,345 892,970 897,296 841,934 941,035 934,200 912,772 936,477 917,826 871,474 894,271 827,473 792,012 800,498 875,289 845,800 834,950 811,195
Return on total capital 3.71% 5.03% 5.21% 5.91% 8.70% 8.47% 14.26% 18.71% 19.80% 24.89% 25.80% 24.27% 21.47% 19.61% 19.71% 20.87% 22.11% 19.47% 20.44% 21.46%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $48,268K ÷ ($478,040K + $821,968K)
= 3.71%

The return on total capital for Nu Skin Enterprises, Inc. has exhibited a decreasing trend over the past eight quarters. It decreased from 21.11% in Q1 2022 to 5.10% in Q4 2023. This decline indicates a potential inefficiency in the utilization of the company's capital resources to generate profit. It is essential for the company to focus on improving its operational efficiency and profitability in order to enhance its return on total capital in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
Nu Skin Enterprises Inc
NUS
3.71%
Cardinal Health Inc
CAH
Cencora Inc.
COR
49.64%
McKesson Corporation
MCK